Literature DB >> 12725797

In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system.

Jeffrey K Harrison1, Defang Luo, Wolfgang J Streit.   

Abstract

The expression of a number of chemokines and chemokine receptors by cells resident in normal and pathological central nervous system (CNS) tissue has been characterized by in situ hybridization techniques. As a result, our understanding of the role of this cytokine family in neurobiology has been enhanced greatly. Specific methods for detecting chemokine and chemokine receptor mRNAs in situ vary with the number of these genes that have been characterized and encompass approaches widely utilized by other investigators characterizing cell-specific gene expression patterns. We describe methods that our laboratory has used successfully in characterizing chemokine and chemokine receptor expression in the CNS, focusing on protocols that utilize radiolabeled in vitro-transcribed riboprobes for detecting these transcripts. Because general dye-based histological staining methods do not readily differentiate astrocytes and microglia, specific immunohistochemical protocols are required for definitive localization of gene expression to these glial cell types. As such, methods that are compatible with the in situ hybridization procedure are included for staining astrocytes and microglia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725797     DOI: 10.1016/s1046-2023(02)00354-7

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  5 in total

1.  CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5.

Authors:  Kien Pham; Defang Luo; Che Liu; Jeffrey K Harrison
Journal:  J Neuroimmunol       Date:  2012-03-16       Impact factor: 3.478

2.  Chemokine receptor CXCR3 promotes growth of glioma.

Authors:  Che Liu; Defang Luo; Brent A Reynolds; Geeta Meher; Alan R Katritzky; Bao Lu; Craig J Gerard; Cyrus P Bhadha; Jeffrey K Harrison
Journal:  Carcinogenesis       Date:  2010-11-03       Impact factor: 4.944

3.  Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas.

Authors:  Katharine M Laughlin; Defang Luo; Che Liu; Gerry Shaw; Kenneth H Warrington; Jingxin Qiu; Anthony T Yachnis; Jeffrey K Harrison
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

4.  Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest.

Authors:  Katharine M Laughlin; Defang Luo; Che Liu; Gerry Shaw; Kenneth H Warrington; Brian K Law; Jeffrey K Harrison
Journal:  Differentiation       Date:  2009-05-07       Impact factor: 3.880

5.  CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes.

Authors:  Che Liu; Defang Luo; Wolfgang J Streit; Jeffrey K Harrison
Journal:  J Neuroimmunol       Date:  2008-05-27       Impact factor: 3.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.